Not too long ago, Contract Development and Manufacturing Organizations (CDMOs) were viewed simply as “the builders”, facilities where pharmaceutical companies outsourced production to save time or reduce costs. Their value was measured in efficiency, compliance, and scale.
In today’s fast-evolving pharmaceutical landscape, speed, scalability, and specialization are critical to success. That’s where Contract Development and Manufacturing Organizations (CDMOs) come in. For pharma innovators, from startups to global giants, CDMOs offer a strategic pathway to bring therapies from lab to...